Stay updated on Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded an Ohio location for the study and updated the 'Last Update Posted' field to 'Estimated'; revision v3.3.3 is now shown.SummaryDifference0.7%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedMinor wording updates were made to the Publications section and to the revision notes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedA banner about government funding lapses and NIH operating status was removed from the page. The rest of the study details remain unchanged.SummaryDifference0.4%

- Check65 days agoChange DetectedNon-significant updates observed, including a newer last update timestamp and minor formatting changes. Core study details such as objectives, eligibility criteria, endpoints, and enrollment remain unchanged.SummaryDifference0.4%

- Check93 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference2%

- Check101 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page.